Medical Device | October 06, 2021
Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion
The transaction is anticipated to close in the first quarter of 2022
The transaction is anticipated to close in the first quarter of 2022
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
_256_384.png){kind=logo}
Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
Anti-malaria API facility will be operational in 15-18 months
The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
Acquisition of A&C expands Aceto’s Western manufacturing footprint
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Subscribe To Our Newsletter & Stay Updated
